Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Sport Sciences for Health
Published in: Sport Sciences for Health 4/2021

01-12-2021 | Insulins | Original Article

The effect of combined resistance aerobic exercise training on concentrations of asprosin and complement C1q tumor necrosis factor-related protein-1 in men with type 2 diabetes

Authors: Mehdi Zarei, Javad Nakhzari Khodakheyr, Amin Rashidlamir, Amir Montazeri

Published in: Sport Sciences for Health | Issue 4/2021

Login to get access

Abstract

Aim

The present study aimed to investigate the effect of combined resistance aerobic exercise training on asprosin and complement C1q tumor necrosis factor-related protein-1 concentrations in men with type 2 diabetes.

Methods

Twenty four male patients with type 2 diabetes were randomized to two combined resistance aerobic exercise training group (n = 12) and control group (n = 12). The combined resistance aerobic exercise training was performed within three sessions per week for 12 weeks. Anthropometric measurements and blood samples were collected at baseline and after 12 weeks. Analysis of covariance was used to compare changes between the groups with pre-test values as covariates.

Results

After 12 weeks, asprosin concentration (p = 0.04), resistance insulin (p = 0.01), HbA1c (p = 0.001), fasting glucose (p = 0.01), weight (p = 0.04), body mass index (0.03), body fat percentage (0.001), total cholesterol (p = 0.04), Triglycerides (p = 0.03) significantly decreased in the exercise group compared to the control group. Significant changes were not observed at the complement C1q tumor necrosis factor-related protein-1 concentration (p = 0.52), WHR (p = 0.29), high-density lipoprotein cholesterol (p = 0.85), low-density lipoprotein cholesterol (p = 0.12), and fat free mass (p = 0.98) between the groups. After 12 weeks in the combined exercise group, low-density lipoprotein cholesterol (p = 0.007) decreased and high-density lipoprotein cholesterol (p = 0.01) increased significantly compared with the baseline. There was a significant positive correlation between asprosin changes with HbA1c(r = 0.44, p = 0.02) and resistance insulin (r = 0.43, p = 0.03) changes.

Conclusion

These findings suggest that combined resistance aerobic exercise training effectively decreases asprosin concentration and improves glycemic control in male patients with type 2 diabetes; however, it has no effect on complement C1q tumor necrosis factor-related protein-1 concentrations.
Literature
1.
Association AD (2018) Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes Care 41 (Supplement 1):S13-S27
2.
Liang W, dong Ye D (2019) The potential of adipokines as biomarkers and therapeutic agents for vascular complications in type 2 diabetes mellitus. Cytokine Growth Factor Rev
3.
Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B (2010) Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care 33(12):e147–e167CrossRef
4.
Stefanyk LE, Dyck DJ (2010) The interaction between adipokines, diet and exercise on muscle insulin sensitivity. Curr Opin Clin Nutr Metab Care 13(3):255–259CrossRef
5.
Berggren JR, Hulver MW, Houmard JA (2005) Fat as an endocrine organ: influence of exercise. J Appl Physiol 99(2):757–764CrossRef
6.
Han S, Kim JD, Lee S, Jeong AL, Park JS, Yong HJ, Boldbaatar A, Ka HI, Rhee E-J, Lee W-Y (2016) Circulating CTRP1 levels in type 2 diabetes and their association with FGF21. Int J Endocrinol. 2016
7.
Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, Saha PK, Del Solar M, Zhu B, York B (2016) Asprosin, a fasting-induced glucogenic protein hormone. Cell 165(3):566–579CrossRef
8.
Zhang X, Jiang H, Ma X, Wu H (2019) Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus. J Diabetes Invest
9.
Duerrschmid C, He Y, Wang C, Li C, Bournat JC, Romere C, Saha PK, Lee ME, Phillips KJ, Jain M (2017) Asprosin is a centrally acting orexigenic hormone. Nat Med 23(12):1444CrossRef
10.
Hosseini ZS, Heydari-Zarnagh H, Behmanesh M, Miri M (2020) Maternal exposure to air pollution and umbilical asprosin concentration, a novel insulin-resistant marker. Chemosphere:129228
11.
Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen Y, Zheng Y, Zheng H (2018) Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Med Inflam 2018
12.
Li X, Liao M, Shen R, Zhang L, Hu H, Wu J, Wang X, Qu H, Guo S, Long M (2018) Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Med Inflam 2018
13.
Yuan M, Li W, Zhu Y, Yu B, Wu J (2020) Asprosin: a novel player in metabolic diseases. Front Endocrinol 11:64CrossRef
14.
Zhang L, Chen C, Zhou N, Fu Y, Cheng X (2019) Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clin Chim Acta 489:183–188CrossRef
15.
Naiemian S, Naeemipour M, Zarei M, Najafi ML, Gohari A, Behroozikhah MR, Heydari H, Miri M (2020) Serum concentration of asprosin in new-onset type 2 diabetes. Diabetol Metab Synd 12(1):1–8CrossRef
16.
Xin Y, Lyu X, Wang C, Fu Y, Zhang S, Tian C, Li Q, Zhang D (2014) Elevated circulating levels of CTRP1, a novel adipokine, in diabetic patients. Endocr J 61(9):841–847CrossRef
17.
Xin Y, Zhang D, Fu Y, Wang C, Li Q, Tian C, Zhang S, Lyu X (2017) C1qtnf-related protein 1 improve insulin resistance by reducing phosphorylation of serine 1101 in insulin receptor substrate 1. Endocr J:EJ17–0128
18.
Peterson JM, Aja S, Wei Z, Wong GW (2012) CTRP1 protein enhances fatty acid oxidation via AMP-activated protein kinase (AMPK) activation and acetyl-CoA carboxylase (ACC) inhibition. J Biol Chem 287(2):1576–1587CrossRef
19.
Seldin MM, Tan SY, Wong GW (2014) Metabolic function of the CTRP family of hormones. Rev Endoc Metab Dis 15(2):111–123CrossRef
20.
Han S, Park JS, Lee S, Jeong AL, Oh KS, Ka HI, Choi H-J, Son W-C, Lee W-Y, Oh SJ (2016) CTRP1 protects against diet-induced hyperglycemia by enhancing glycolysis and fatty acid oxidation. J Nutri Biochem 27:43–52CrossRef
21.
Pan X, Lu T, Wu F, Jin L, Zhang Y, Shi L, Li X, Lin Z (2014) Circulating complement-C1q TNF-related protein 1 levels are increased in patients with type 2 diabetes and are associated with insulin sensitivity in Chinese subjects. PLoS One 9 (5)
22.
Rodriguez S, Lei X, Petersen PS, Tan SY, Little HC, Wong GW (2016) Loss of CTRP1 disrupts glucose and lipid homeostasis. Am J Physiol Endocrinol Metab 311(4):E678–E697CrossRef
23.
Han S, Yang Y (2018) A novel blood pressure modulator C1q/TNF-α–related protein 1 (CTRP1). BMB Rep 51(12):611CrossRef
24.
Yagmur E, Buergerhausen D, Koek GH, Weiskirchen R, Trautwein C, Koch A, Tacke F (2019) Elevated CTRP1 plasma concentration is associated with sepsis and pre-existing type 2 diabetes mellitus in critically Ill patients. J Clin Med 8(5):661CrossRef
25.
Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, Horton ES, Castorino K, Tate DF (2016) Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 39(11):2065–2079CrossRef
26.
Hansen D, Peeters S, Zwaenepoel B, Verleyen D, Wittebrood C, Timmerman N, Schotte M (2013) Exercise assessment and prescription in patients with type 2 diabetes in the private and home care setting: clinical recommendations from AXXON (Belgian Physical Therapy Association). Phys Ther 93(5):597–610CrossRef
27.
Hordern MD, Dunstan DW, Prins JB, Baker MK, Singh MAF, Coombes JS (2012) Exercise prescription for patients with type 2 diabetes and pre-diabetes: a position statement from Exercise and Sport Science Australia. J Sci Med Sport 15(1):25–31CrossRef
28.
Brzycki M (1993) Strength testing—predicting a one-rep max from reps-to-fatigue. J Phys Educ Recreat Dance 64(1):88–90CrossRef
29.
Sigal RJ, Armstrong MJ, Bacon SL, Boule NG, Dasgupta K, Kenny GP, Riddell MC (2018) Physical activity and diabetes. Can J Diabetes 42:S54–S63CrossRef
30.
AminiLari Z, Fararouei M, Amanat S, Sinaei E, Dianatinasab S, AminiLari M, Daneshi N, Dianatinasab M (2017) The effect of 12 weeks aerobic, resistance, and combined exercises on omentin-1 levels and insulin resistance among type 2 diabetic middle-aged women. Diabetes Metab J 41(3):205–212CrossRef
31.
Jorge MLMP, de Oliveira VN, Resende NM, Paraiso LF, Calixto A, Diniz ALD, Resende ES, Ropelle ER, Carvalheira JB, Espindola FS (2011) The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism 60(9):1244–1252CrossRef
32.
Church TS, Blair SN, Cocreham S, Johannsen N, Johnson W, Kramer K, Mikus CR, Myers V, Nauta M, Rodarte RQ (2010) Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA 304(20):2253–2262CrossRef
33.
Greenhill C (2016) Liver: asprosin—new hormone involved in hepatic glucose release. Nat Rev Endocrinol 12(6):312CrossRef
34.
Ko JR, Seo DY, Kim TN, Park SH, Kwak H-B, Ko KS, Rhee BD, Han J (2019) Aerobic exercise training decreases hepatic asprosin in diabetic rats. J Clin Med 8(5):666CrossRef
35.
Nakhaei H, Mogharnasi M, Fanaei H (2019) Effect of swimming training on levels of asprosin, lipid profile, glucose and insulin resistance in rats with metabolic syndrome. Obes Med 15:100111CrossRef
36.
Kajimura S (2017) Advances in the understanding of adipose tissue biology. Nat Rev Endocrinol 13(2):69–70CrossRef
37.
Salminen A, Kaarniranta K, Kauppinen A (2016) Age-related changes in AMPK activation: role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways. Age Res Rev 28:15–26CrossRef
38.
Ferretti AC, Tonucci FM, Hidalgo F, Almada E, Larocca MC, Favre C (2016) AMPK and PKA interaction in the regulation of survival of liver cancer cells subjected to glucose starvation. Oncotarget 7(14):17815CrossRef
39.
Wang M, Yin C, Wang L, Liu Y, Li H, Li M, Yi X, Xiao Y (2019) Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity. Ann Nutr Metab 75(4):205–212CrossRef
40.
Wiecek M, Szymura J, Maciejczyk M, Kantorowicz M, Szygula Z (2018) Acute anaerobic exercise affects the secretion of Asprosin, Irisin, and other cytokines–a comparison between sexes. Front Physiol 9:1782CrossRef
41.
42.
Schäffler A, Buechler C (2012) CTRP family: linking immunity to metabolism. Trends Endocrinol Metab 23(4):194–204CrossRef
43.
Shabani P, Emamgholipour S, Doosti M (2017) CTRP1 in liver disease. In: Advances in clinical chemistry, vol 79. Elsevier, pp 1–23
44.
Kon M, Ebi Y, Nakagaki K (2019) Effects of a single bout of high-intensity interval exercise on C1q/TNF-related proteins. Appl Physiol Nutr Metab 44(1):47–51CrossRef
45.
46.
Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD, Alevizos M (2007) The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovascu Prevent Rehabilit 14(6):837–843CrossRef
47.
Metadata
Title
The effect of combined resistance aerobic exercise training on concentrations of asprosin and complement C1q tumor necrosis factor-related protein-1 in men with type 2 diabetes
Authors
Mehdi Zarei
Javad Nakhzari Khodakheyr
Amin Rashidlamir
Amir Montazeri
Publication date
01-12-2021
Publisher
Springer Milan
Published in
Sport Sciences for Health / Issue 4/2021
Print ISSN: 1824-7490
Electronic ISSN: 1825-1234
DOI
https://doi.org/10.1007/s11332-021-00738-7

Other articles of this Issue 4/2021

Sport Sciences for Health 4/2021 Go to the issue

Original Article

Acute and delayed impairments of muscle function after a sprint training session performed at different exercise regimens

Original Article

Influence of stress relaxation and load during static stretching on the range of motion and muscle–tendon passive stiffness

Original Article

Individuals’ depression and anxiety might be influenced by the level of physical activity and expertise: a pilot study on elite volleyball players and amateur athletes

Original Article

Good functional outcomes in patient’s age > 40 years after anterior cruciate ligament reconstruction with hamstring tendon graft: a retrospective study

Short Communication

Energy matching of a high-intensity exercise protocol with a low-intensity exercise protocol in young people

Original Article

Regular resistance training favorably affects central artery stiffness response following transient resistance exercise